Treating the Untreatable
THE CHALLENGE
For decades, neuromodulation technologies have largely focused on neuropathic pain, while nociceptive pain remained overlooked. As a result, many patients with chronic nociceptive pain have endured repeated treatment failures with limited options for relief.
Beyond the Diagnostic
Accurate diagnosis is only the beginning. Patients with cancer, neurological, immune, and rare diseases often face limited treatment options and persistent symptoms despite current therapies. Genventis goes beyond diagnosis by developing targeted interventions that address the root causes of disease, aiming to provide meaningful, lasting relief where conventional approaches fall short.
THE CHALLENGE
We solve the tough challenges.
Genventis’s Innovation Science platform combines molecular biology, computational modeling, and translational research to advance precision therapies in Oncology, Neurology, Immunology, and Rare Diseases—targeting complex disease mechanisms to improve patient outcomes.
In Oncology, Neurology, Autoimmune/Immune, and Rare Disease research, Genventis applies deep expertise in cellular engineering, immune modulation, and neurocircuit analysis to translate discovery into meaningful therapeutics. By combining innovative science with clinical insight, we aim to transform the way diseases are treated—delivering targeted, durable, and life-changing therapies for patients worldwide.
SCIENCE & INNOVATION
Driving Change for People With Cancer and Rare Disease
Genventis’s Innovation Science platform combines molecular biology, computational modeling, and translational research to advance precision therapies in Oncology, Neurology, Immunology, and Rare Diseases—targeting complex disease mechanisms to improve patient outcomes.
THE GENVENTIS DIFFERENCE
Inhibiting Neurons. Unleashing a New Wave in Treating
Respiratory
Genventis is built to make waves—bringing hope to patients with untreatable nociceptive pain and other conditions driven by undesired neural activity. Our journey is just beginning.
The Future with GVT
GVT is designed to make waves in helping patients with untreatable nociceptive pain and other diseases of undesired neural activity. The journey is just beginning!
A CULTURE OF CURIOSITY
We find the answers together.
By empowering our teams and nurturing strong collaborations, we create lasting value and impact.
Innovation
What is One Pipeline
Explore our science
How Geventis scientists are driving generation cancer research
Patients
A candid conversation about diversity in clinical trials
ENVIRONMENTAL, SOCIAL AND GOVERNANCE
We make an impact that lasts.
Our impact is built to last. By leading with purpose, we make courageous decisions that improve lives and create lasting value for patients, families, and our people.
Environmental, Social & Governance (ESG)
Find out how we're supporting the future of our business and the well-being of patients, people, and communities around the world.
Media
Our latest news, announcements and multimedia resources
Sustainability
Our science-led strategy is key to delivering long-term value for patients, employees, and shareholders.
